|
|
|
|
|
|
|
|
|
The New Economics of Biologics: Breaking the $50/g Barrier — Now
|
When does process intensification become the stronger economic choice for mAb manufacturing? The answer depends on production volume, titer, facility utilization, and process configuration. In our new report, modeling results show how different manufacturing scenarios influence cost of goods — and where intensified single-use and continuous approaches can support costs below $50/g. Read the report to explore the economics behind the next generation of biologics manufacturing.
|
|
|
|
|
|
Webinar | ATUM
|
Learn about high throughput biologic automation and GMP master cell banking services as well as variable selection services that search the SQL space to find promoters.
|
|
|
|
|
|
Video | Thermo Fisher Scientific
|
See how media options can help support scale-up, reduce handling steps, and improve workflow efficiency in cell therapy manufacturing.
|
|
|
|
|
|
Video | Bioprocess Online
|
In this segment from the Bioprocess Online Live event, our panelists respond to an audience poll and answer audience questions about hollow fiber membranes and process modeling approaches. They agree that productivity gains emerge from a comprehensive understanding of the process and the tools that enable it.
|
|
|
|
|
|
Webinar | Emerson
|
Unlock smarter pharmaceutical data management with an innovative platform to streamline compliance, accelerate tech transfer, and harness real-time insights to drive innovation.
|
|
|
|
|
|
Webinar | Waters Corporation
|
Explore the expanding role of synthetic peptides in drug development, as well as how advanced RP chromatography methods are vital for impurity profiling to ensure safety and efficacy.
|
|
|
|
|
|
Webinar | Primrose Bio
|
Discover how high-throughput microbial screening identifies optimal expression strains for complex biotherapeutics, significantly reducing the time required to validate computational designs.
|
|
|
| Connect With Bioprocess Online: |
|
|
|
|
